Skip to content
Home
About Us
Log In
News
All News
Finance
Treatment
People
Research
Videos
Treatments
Clinical Trials
Access Programs
About Access Programs
Diseases
Events
Networks
Research
Main Menu
×
Subscribe for Free Newsletter
Email
*
Type
*
Supporter
Researcher
Physician
Patient
Medical Student
Medical Industry
* Required Field
Email Marketing Services
by Benchmark
×
Generate RSS
Select number of items
10
25
50
100
Home
/
Video
/
Tyrosinemia Type I
Tyrosinemia Type I
September 28, 2012
[email protected]
Tyrosinemia Type I
News
Sangrail Biologics Launches with Lead Gene Therapy SNG-101 For Mucopol
Neuraly Announces First Patient Dosed in Phase 2 Trial of Pegsebrenati
Hepta Reveals Blood-Based Epigenetic Signatures of GLP-1 Response, Ena
Opus Genetics’ Gene Therapy for Leber Congenital Amaurosis Type 5 Ac
Cellenkos Inc. Receives U.S. Food And Drug Administration Clearance to
More News